Management of seizures in critically ill patients

Current Neurology and Neuroscience Reports

Volumn 4, Issue 6, 2004, Pages 489-496

  Varelas, Panayiotis N ^a   Mirski, Marek A ^b  

^a FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMOXAPINE; ANTICONVULSIVE AGENT; AZTREONAM; CARBAMAZEPINE; CLOBAZAM; DIAZEPAM; DOXEPIN; ETIRACETAM; FELBAMATE; FLUPHENAZINE; FOSPHENYTOIN SODIUM; GABAPENTIN; ISONIAZID; LAMOTRIGINE; MAPROTILINE; METRONIDAZOLE; MIDAZOLAM; OXCARBAZEPINE; PENICILLIN DERIVATIVE; PHENYTOIN; PROPOFOL; THEOPHYLLINE; TIAGABINE; TOPIRAMATE; TRAZODONE; UNINDEXED DRUG; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ANOREXIA; APLASTIC ANEMIA; ATAXIA; BODY WEIGHT DISORDER; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CRITICAL ILLNESS; DEPRESSION; DIPLOPIA; DISEASE EXACERBATION; DIZZINESS; DROWSINESS; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG ERUPTION; DRUG HALF LIFE; EVIDENCE BASED MEDICINE; FATIGUE; HEAD INJURY; HEADACHE; HEALTH CARE MANAGEMENT; HEPATITIS; HOSPITAL DISCHARGE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INCIDENCE; INFECTION; INTENSIVE CARE UNIT; MEDICAL DECISION MAKING; MYOCLONUS; NEPHROLITHIASIS; NEUTROPENIA; NONHUMAN; PARESTHESIA; POPULATION RESEARCH; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SEIZURE; SOMNOLENCE; SUBARACHNOID HEMORRHAGE;

EID: 9744245325     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-004-0074-9     Document Type: Review

References (94)

1. Bleck TP, Smith MC, Pierre-Louis SJ, et al.: Neurologic complications of critical medical illnesses. Crit Care Med 1993, 21:98-103.
2. Varelas PN, Mirski MA: Seizures in the adult intensive care unit. J Neurosurg Anesthesiol 2001, 13:163-175.
3. Mirski MA, Varelas PN: Diagnosis and treatment of seizures in the adult Intensive Care Unit. Contemp Crit Care 2003, 1: -12.
4. Seizures in Critical Care. In A Guide to Diagnosis and Therapeutics. Edited by Varelas PN. Totowa, NJ: Humana Press; 2004: In press.
5. Bladin CF, Alexandrov AV, Bellavance A, et al.: Seizures after stroke: a prospective multicenter study. Arch Neurol 2000, 57:1617-1622.
6. Burn J, Dennis M, Bamford J, et al.: Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 1997, 315:1582-1587.
7. Kilpatrick CJ, Davis SM, Tress BM, et al.: Epileptic seizures in acute stroke. Arch Neurol 1990, 47:157-160.
8. Milandre L, Broca P. Sambuc P, Khalil R: Epileptic crisis during and after cerebrovascular diseases. A clinical analysis of 78 cases. Rev Neurol 1992, 148:767-772.
9. Arboix A, Comes E, Massons J, et al.: Relevance of early seizures for in-hospital mortality in acute cerebrovascular disease. Neurology 1996, 47:1429-1435.
10. Reith J, Jorgensen HS, Nakayama H, et al.: Seizures in acute stroke: predictors and prognostic significance. The Copenhagen Stroke Study. Stroke 1997, 28:1585-1589.
11. Lancman ME, Golimstok A, Norscini J, Granillo R: Risk factors for developing seizures after a stroke. Epilepsia 1993, 34:141-143.
12. Lamy C, Domigo V, Semah F, et al.: Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 2003, 60:400-404.
13. Paolucci S, Silvestri G, Lubich S, et al.: Poststroke late seizures and their role in rehabilitation of inpatients. Epilepsia 1997, 38:266-270.
14. Berges S, Moulin T, Berger E, et al.: Seizures and epilepsy following strokes: recurrence factors. Eur Neurol 2000, 43:3-8.
15. Labovitz DL, Hauser WA, Sacco RL: Prevalence and predictors of early seizure and status epilepticus after first stroke. Neurology 2001, 57:200-206.
16. Rumbach L, Sablot D, Berger E, et al.: Status epilepticus in stroke: report on a hospital-based stroke cohort. Neurology 2000, 54:350-354.
17. Sung CY, Chu NS: Epileptic seizures in thrombotic stroke. J Neurol 1990, 237:166-170.
18. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995, 333:1581-1587.
19. Devuyst G, Karapanayiotides T, Hottinger I, et al.: Prodromal and early epileptic seizures in acute stroke: does higher serum cholesterol protect? Neurology 2003, 61:249-252.
20. Gilad R, Lampl Y, Eschel Y, Sadeh M: Antiepileptic treatment in patients with early postischemic stroke seizures: a retrospective study. Cerebrovasc Dis 2001, 12:39-43.
21. Adams HP Jr, Adams RJ, Brott T, et al.: Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003, 34:1056-1083.
22. Silverman IE, Restrepo L, Mathews GC: Poststroke seizures. Arch Neurol 2002, 59:195-201.
23. Alvarez-Sabin J, Montaner J, Padro L, et al.: Gabapentin in late-onset poststroke seizures. Neurology 2002, 59:1991-1993.
24. Giroud M, Gras P, Fayolle H, et al.: Early seizures after acute stroke: a study of 1,640 cases. Epilepsia 1994, 35:959-964.
25. Sung CY, Chu NS: Epileptic seizures in intracerebral haemorrhage. J Neurol Neurosurg Psychiatry 1989, 52: 273-1276.
26. Faught E, Peters D, Bartolucci A, et al.: Seizures after primary intracerebral hemorrhage. Neurology 1989, 39: 089-1093.
27. Passero S, Rocchi R, Rossi S, et al.: Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia 2002, 43:1175-1180.
28. Tatu L, Moulin T, El Mohamad R, et al.: Primary intracerebral hemorrhages in the Besancon stroke registry. Initial clinical and CT findings, early course and 30-day outcome in 350 patients. Eur Neurol 2000, 43:209-214.
29. Vespa PM, O'Phelan K, Shah M, et al.: Acute seizures after intracerebral hemorrhage: A factor in progressive midline shift and outcome. Neurology 2003, 60:1441-1446.
30. Daniele O, Caravaglios G, Ferraro G, et al.: Stroke-related seizures and the role of cortical and subcortical structures. J Epilepsy 1996, 9:184-188.
31. Broderick JP, Adams HP Jr, Barsan W, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999, 30:905-915.
32. Berger AR, Lipton RB, Lesser ML, et al.: Early seizures following intracerebral hemorrhage: implications for therapy. Neurology 1988, 38:1363-1365.
33. Diringer MN: Intracerebral hemorrhage: pathophysiology and management. Crit Care Med 1993, 21:1591-1603.
34. Cervoni L, Artico M, Salvati M, et al.: Epileptic seizures in intracerebral hemorrhage: a clinical and prognostic study of 55 cases. Neurosurg Rev 1994, 17:185-188.
35. Qureshi AI, Tuhrim S, Broderick JP, et al.: N Engl J Med 2001, 344:1450-1460.
36. Ohman J: Hypertension as a risk factor for epilepsy after aneurysmal subarachnoid hemorrhage and surgery. Neurosurgery 1990, 27:578-581.
37. Pinto AN, Canhao P, Ferro JM: Seizures at the onset of subarachnoid haemorrhage. J Neurol 1996, 243:161-164.
38. Hasan D, Schonck RS, Avezaat CJ, et al.: Epileptic seizures after subarachnoid hemorrhage. Ann Neurol 1993, 33: 86-291.
39. Butzkueven H, Evans AH, Pitman A, et al.: Onset seizures independently predict poor outcome after subarachnoid hemorrhage. Neurology 2000, 55:1315-1320.
40. Hart RG, Byer JA, Slaughter JR, et al.: Occurrence and implications of seizures in subarachnoid hemorrhage due to ruptured intracranial aneurysms. Neurosurgery 1981, 8:417-421.
41. Rhoney DH, Tipps LB, Murry KR, et al.: Anticonvulsant prophylaxis and timing of seizures after aneurysmal subarachnoid hemorrhage. Neurology 2000, 55:258-265.
42. Rosengart AJ, Novakovic R, Dezheng H, et al.: Impact of prophylactic anticonvulsive use on outcome in subarachnoid hemorrhage. Stroke 2004, 35:250.
43. Foy PM, Chadwick DW, Rajgopalan N, et al.: Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy? J Neurol Neurosurg Psychiatry 1992, 55: 53-757.
44. Sbeih I, Tamas LB, O'Laoire SA: Epilepsy after operation for aneurysms. Neurosurgery 1986, 19:784-788.
45. Bidzinski J, Marchel A, Sherif A: Risk of epilepsy after aneurysm operations. Acta Neurochir (Wien) 1992, 119: 9-52.
46. Baker CJ, Prestigiacomo CJ, Solomon RA: Short-term perioperative anticonvulsant prophylaxis for the surgical treatment of low-risk patients with intracranial aneurysms. Neurosurgery 1995, 37:863-870; discussion 870-871.
47. Byrne JV, Boardman P, Ioannidis I, et al.: Seizures after aneurysmal subarachnoid hemorrhage treated with coil embolization. Neurosurgery 2003, 52:545-552; discussion 550-552.
48. Maramattom BV, Britton J, Wijdicks EF: Ictal bradycardia after endovascular aneurysm treatment. Neuroctitical Care 2004, 1:265.
49. Salazar AM, Jabbari B, Vance SC, et al.: Epilepsy after penetrating head injury. I. Clinical correlates: a report of the Vietnam Head Injury Study. Neurology 1985, 35:1406-1414.
50. Lee ST, Lui TN, Wong CW, et al.: Early seizures after moderate closed head injury. Acta Neurochir (Wien) 1995, 137:151-154.
51. Vespa PM, Nuwer MR, Nenov V, et al.: Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg 1999, 91:750-760.
52. Frey LC: Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 2003, 44(Suppl 10): 11-17.
53. Temkin NR: Risk factors for posttraumatic seizures in adults. Epilepsia 2003, 44 (Suppl 10):18-20.
54. Ottman P, Lee JH, Risch N, et al.: Clinical indicators of genetic susceptibility to epilepsy. Epilepsia 1996, 37:353-361.
55. Diaz-Arrastia R, Gong Y, Fair S, et al.: Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Arch Neurol 2003, 60:818-822.
56. Temkin NR, Dikmen SS, Wilensky AJ, et al.: A randomized, double-blind study of phenytoin for the prevention of posttraumatic seizures. N Engl J Med 1990, 323:497-502.
57. Temkin NR, Dikmen SS, Anderson GD, et al.: Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg 1999, 91:593-600.
58. The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care: Role of antiseizure prophylaxis following head injury. J Neurotrauma 2000, 17:549-553.
59. Chang BS, Lowenstein DH: Practice parameter: antiepileptic drug prophylaxis in severe traumatic brain injury: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2003, 60:10-16.
60. Wallace KL: Antibiotic-induced convulsions. Crit Care Clin 1997, 13:741-762.
61. Kumar A, Bleck TP: Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med 1992, 20: 83-488.
62. Rosenstein DL, Nelson JC, Jacobs SC: Seizures associated with antidepressants: a review. J Clin Psychiatry 1993, 54: 89-299.
63. Lee KC, Finley PR, Alldredge BK: Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Safety 2003, 2:233-247.
64. Alldredge BK: Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology 1999, 53:S68-S75.
65. Pisani F, Oteri G, Costa C, et al.: Effects of psychotropic drugs on seizure threshold. Drug Safety 2002, 25:91-110.
66. Lowenstein DH, Alldredge BK: Status epilepticus at an urban public hospital in the 1980s. Neurology 1993, 43: 83-488.
67. Towne AR, Pellock JM, Ko D, DeLorenzo RJ: Determinants of mortality in status epilepticus. Epilepsia 1994, 35:27-34.
68. Mayer SA, Claassen J, Lokin J, et al.: Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002, 59:205-210.
69. Duncan JS: The promise of new antiepileptic drugs. Br J Clin Pharmacol 2002, 53:123-131.
70. Pandey CK, Singh N, Bose N, Sahay S: Gabapentin and propofol for treatment of status epilepticus in acute intermittent porphyria. J Postgrad Med 2003, 49:285.
71. Barrueto F Jr, Green J, Howland MA, et al.: Gabapentin withdrawal presenting as status epilepticus. J Toxicol Clin Toxicol 2002, 40:925-928.
72. Krauss GL, Simmons-O'Brien E, Campbell M: Successful treatment of seizures and porphyria with gabapentin. Neurology 1995, 45:594-595.
73. Pisani F, Gallitto G, Di Perri R: Could lamotrigine be useful in status epilepticus? A case report. J Neurol Neurosurg Psychiatry 1991, 54:845-846.
74. Trinka E, Dilitz E, Unterberger I, et al.: Non convulsive status epilepticus after replacement of valproate with lamotrigine. J Neurol 2002, 249:1417-1422.
75. Guerrini R, Belmonte A, Parmeggiani L, Perucca E: Myoclonic status epilepticus following high-dosage lamotrigine therapy. Brain Dev 1999, 21:420-424.
76. Paul F, Meencke HJ: Levetiracetam in focal epilepsy and hepatic porphyria: a case report. Epilepsia 2004, 45: 59-560.
77. Towne AR, Garnett LK, Waterhouse EJ, et al.: The use of topiramate in refractory status epilepticus. Neurology 2003, 60:332-334.
78. Bensalem MK, Fakhoury TA: Topiramate and status epilepticus: report of three cases. Epilepsy Behav 2003, 4: 57-760.
79. Reuber M, Evans J, Bamford JM: Topiramate in drug-resistant complex partial status epilepticus. Eur J Neurol 2002, 9:111-112.
80. Skardoutsou A, Voudris KA, Vagiakou EA: Non-convulsive status epilepticus associated with tiagabine therapy in children. Seizure 2003, 12:599-601.
81. Kellinghaus C, Dziewas R, Ludemann P: Tiagabine-related non-convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature. Seizure 2002, 11:243-249.
82. Loscher W, Honack D: Intravenous carbamazepine: comparison of different parenteral formulations in a mouse model of convulsive status epilepticus. Epilepsia 1997, 38:106-113.
83. So EL, Ruggles KH, Cascino GD, et al.: Seizure exacerbation and status epilepticus related to carbamazepine-10, 11-epoxide. Ann Neurol 1994, 35:743-746.
84. Osorio I, Reed RC, Peltzer JN: Refractory idiopathic absence status epilepticus: a probable paradoxical effect of phenytoin and carbamazepine. Epilepsia 2000, 41:887-894.
85. Callahan DJ, Noetzel MJ: Prolonged absence status epilepticus associated with carbamazepine therapy, increased intracranial pressure, and transient MRI abnormalities. Neurology 1992, 42:2198-2201.
86. Spiller HA, Carlisle RD: Status epilepticus after massive carbamazepine overdose. J Toxicol Clin Toxicol 2002, 40: 1-90.
87. Gaida-Hommernick B, Rieck K, Runge U: Oxcarbazepine in focal epilepsy and hepatic porphyria: a case report. Epilepsia 2001, 42:793-795.
88. Prasad A, Worrall BB, Bertram EH, Bleck TP: Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia 2001, 42:380-386.
89. Walder B, Tramer MR, Seeck M: Seizure-like phenomena and propofol: a systematic review. Neurology 2002, 58: 327-1332.
90. Cremer OL, Moons KG, Bouman EA, et al.: Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001, 357:117-118.
91. Galdames D, Aguilera M, Fabres L: Midazolam in the treatment of status epilepticus and frequent seizures in adults. Epilepsia 1997, 38:12.
92. Chamberlain JM, Altieri MA, Futterman C, et al.: A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr Emerg Care 1997, 13:92-94.
93. Towne AR, DeLorenzo RJ: Use of intramuscular midazolam for status epilepticus. J Emerg Med 1999, 17:323-328.
94. Shorvon S: Antiepileptic drugs. In Handbook of Epilepsy Treatment. Edited by Shorvon S. Oxford, UK: Blackwell Science; 2000:85-172.